Anne W J Martens

5PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2026
Necroptotic cell death and immunomodulator release induced by T-cell engaging anti-lymphoma therapies.

|Jul 06, 2022
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.

Lakshmanan Krishnamurti, Staci D Arnold, Ann Haight

|Oct 13, 2021
Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837.

Jaco A C van Bruggen, Anne W J Martens, Sanne H Tonino

|Dec 23, 2020
Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma.

Jaco A C van Bruggen, Anne W J Martens, Sanne H Tonino

|Jun 26, 2020
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.

Anne W J Martens, Susanne R Janssen, Ingrid A M Derks

Pageof 1

Frequent Collaborators

1 joint publications

Demi Both

1 joint publications

Ingrid Derks

1 joint publications

Arnon Kater

1 joint publications

Marco Haselager